Impact of EGFR pathway inhibition on immunogenicity of head and neck squamous cell carcinoma

J De Azevedo - 2022 - theses.hal.science
Head and neck squamous cells carcinoma develop in the oral cavity, pharynx and larynx
and have a low 5-year survival rate of approximately 40% due to the resistance of cancer …
相关文章

Impact of EGFR pathway inhibition on immunogenicity of head and neck squamous cell carcinoma

J de Azevedo - 2022 - hal.science
Head and neck squamous cells carcinoma develop in the oral cavity, pharynx and larynx
and have a low 5-year survival rate of approximately 40% due to the resistance of cancer …

Impact of EGFR pathway inhibition on immunogenicity of head and neck squamous cell carcinoma

J de Azevedo - 2022 - inria.hal.science
Head and neck squamous cells carcinoma develop in the oral cavity, pharynx and larynx
and have a low 5-year survival rate of approximately 40% due to the resistance of cancer …

Impact of EGFR pathway inhibition on immunogenicity of head and neck squamous cell carcinoma

J de Azevedo - 2022 - hal.insa-toulouse.fr
Head and neck squamous cells carcinoma develop in the oral cavity, pharynx and larynx
and have a low 5-year survival rate of approximately 40% due to the resistance of cancer …

Impact of EGFR pathway inhibition on immunogenicity of head and neck squamous cell carcinoma

J De Azevedo - 2022 - theses.fr
Résumé Les carcinomes épidermoïdes de la tête et du cou se développent dans la cavité
buccale, le pharynx et le larynx et ont un faible taux de survie à 5 ans d'environ 40% en …

Impact of EGFR pathway inhibition on immunogenicity of head and neck squamous cell carcinoma

J de Azevedo - 2022 - hal.em-lyon.com
Head and neck squamous cells carcinoma develop in the oral cavity, pharynx and larynx
and have a low 5-year survival rate of approximately 40% due to the resistance of cancer …